← Back to Search

Tegaderm vs. Transpore Eye Tape for Eyelid Redness

N/A
Recruiting
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Surgeries scheduled for anesthesia of any duration
At least 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after tape removal
Awards & highlights

Study Summary

This trial will compare the rate of erythema, or redness, on the eyelids after anesthesia when a TegadermTM patch is used compared to a Transpore® patch. The hypothesis is that there will be no difference in the rate of erythema between the two groups.

Who is the study for?
This trial is for adults over 18 who are scheduled for any surgery requiring anesthesia, except surgeries involving the head, neck, face, eyes or mouth. It's not for those with pre-existing eyelid redness or trauma, eyelid piercings, or anyone undergoing surgery in a prone position.Check my eligibility
What is being tested?
The study aims to compare Tegaderm Eye Tape and Transpore Eye Tape to see if there's a difference in causing eyelid redness after anesthesia. Participants will be randomly assigned one of the two tapes during their procedure.See study design
What are the potential side effects?
Potential side effects may include irritation at the tape application site leading to redness of the eyelids (eyelid erythema) following removal post-anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery that requires anesthesia.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after tape removal
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after tape removal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The proportion of eyelids with erythema at the end of surgery after removal of Tegaderm vs. Transpore
Secondary outcome measures
Edema
Epidermal Change

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transpore RightExperimental Treatment1 Intervention
After general anesthesia is administered, Transpore will be placed on the right eye and Tegaderm will be placed on the left eye.
Group II: Tegaderm LeftExperimental Treatment1 Intervention
After general anesthesia is administered, Tegaderm will be placed on the left eye and Transpore will be placed on the right eye

Find a Location

Who is running the clinical trial?

Tufts Medical CenterLead Sponsor
256 Previous Clinical Trials
255,572 Total Patients Enrolled

Media Library

Eye Protection Clinical Trial Eligibility Overview. Trial Name: NCT04918290 — N/A
Eyelid Redness Research Study Groups: Tegaderm Left, Transpore Right
Eyelid Redness Clinical Trial 2023: Eye Protection Highlights & Side Effects. Trial Name: NCT04918290 — N/A
Eye Protection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04918290 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Tegaderm Eye Tape present any potential hazards for users?

"Considering that Tegaderm Eye Tape is approved, and thus extensively tested for safety, our analysts rated it with a score of 3."

Answered by AI

What is the upper limit for individuals enrolled in this investigation?

"Affirmative. The clinicaltrials.gov registry indicates that this trial, which was first posted on June 11th 2021, is actively recruiting participants from a single site. A total of 165 volunteers are required to complete the study."

Answered by AI

Are there still open slots to participate in this experiment?

"Affirmative. As per the information found on clinicaltrials.gov, this trial is actively seeking participants and has been since it was published on June 11th 2021. The most recent update to the study details was made April 26th 2022, which outlines a recruitment target of 165 patients from one medical centre."

Answered by AI
~42 spots leftby May 2025